CME vs LIMNW
CME Group Inc (CME) versus Liminatus Pharma, Inc. Warrants (LIMNW) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
LIMNW does not have a complete income-statement cache yet.
CME currently screens at market cap $91.25B and trailing P/E 21.9. LIMNW currently screens at market cap $0.
Not investment advice. Open the CME and LIMNW stock pages for the full models.
Not investment advice.